2026
Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies., Mohammad Alhomoud; Franco Castillo Tokumori; Nora Chokr; Joshua Fein; Daniel C Choi; Usama Gergis MD, MBA; Adrienne Phillips; Jingmei Hsu; Alexandra Gomez-Arteaga; Tsiporah Shore; Zhengming Chen; Joseph Scandura; Koen van Besien; and Sebastian Mayer (Article)
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6., David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, Fernando Vargas Madueno, Sami Ibrahimi, Seema Naik, Mitul Gandhi, Julie Erika Haydu, Bradley Lash MD, Mark Fesler, John Hrom, Eric H Lee, Suchitra Sundaram, Kristin Conte, Kojo Osei-Bonsu, Thomas Doerr, Yang Bai, Neha Dixit, Christian W Eskelund, Alexander P Boardman, Ralph Boccia, Christina Y Lee, and Jeff P Sharman (Article)
Myosin 5A mediates membrane-associated periodic skeleton reassembly during axon regeneration in response to ROCK-2 inhibition., Atrayee Basu, Elisa M Howard, Tanina Arab, Nabab Khan, Jean Kanyo, TuKiet Lam, and Stephen M Strittmatter (Article)
RINGSIDE: A phase 3 randomized, placebo-controlled trial of varegacestat for treatment of progressing desmoid tumors, A Basu Mallick (Article)
Specialist referral patterns and relationship to outcomes in patients with hepatocellular carcinoma., A Basu Mallick and S J. Cohen (Article)
Superior Long-Term Survival with Fludarabine-Melphalan RIC Regimen in Older AML/MDS Patients: A Propensity Score Analysis of CIBMTR Data, Xia Bi MD, MS (Article)
Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies - A Prospective Trial., Xia Bi; Boula Gattas; Dolores Grosso; Onder Alpdogan; Alicia Bao; Allison Gradone; Arpona Dev Nath; Joanne Filicko-O'Hara; William O'Hara; Joseph Van Galen; Lindsay Wilde; Chetan Jeurkar; Margaret T Kasner; Gina Keiffer; John L Wagner; Neal Flomenberg; and Usama Gergis MD, MBA (Article)
The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with Myelofibrosis., Xia Bi; Shaik Rashid; Joanne Filicko-O'Hara; Joseph Van Galen; William O'Hara; John L Wagner; Dolores Grosso; Neal Flomenberg; and Usama Gergis MD, MBA (Article)
Efficacy and safety of pralsetinib in advanced or metastatic RET-altered thyroid cancer (TC): Final analysis of the phase 1/2 ARROW study, M Brose (Article)
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status., Marcia S Brose, Bhumsuk Keam, Jolanta Krajewska, Ana O Hoff, Fernanda Vaisman, Chia-Chi Lin, Erika Hitre, Daniel W Bowles, Bruce Robinson, Steven I Sherman, Nuttapong Ngamphaiboon, Xiang Guo, Andrew Simmons, Denise Williamson, Svetlana Andrianova, Nicholas Berry, and Jaume Capdevila (Article)
Artificial intelligence comparison of Google MedGemma and ChatGPT-5 in expert-reviewed gastrointestinal and genitourinary oncology cases, S J. Cohen (Article)
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma., Justin M Darrah; Indumathy Varadarajan; Amitkumar Mehta; Jennifer N Saultz; Matthew S McKinney; Monalisa Ghosh; Usama Gergis MD, MBA; Andrew Krueger; Kevin J Galinsky; Girish Bende; Ajeetha Ramachandran; Varsha Sundaresan; Siddha Kasar; Bradley Hupf; Sharon Chen; Leopold Sellner; and Reem Karmali (Article)
Implementation Readiness for National Cancer Survivorship Care Standards., Christiane J El Khoury, Meera Gupta, Maryem Shirzadi, Heidi Dowst, Martha Mims, Maysa Abu-Khalaf, and Hoda Badr (Article)
Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (, Usama Gergis MD, MBA (Article)
Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer., Brittney Greene, Shilpa Ghosh, Craig Colder, Salimah Meghani, Brooke Worster, and Rebecca Ashare (Article)
Closing Remarks/Key Takeaways, Ranju Gupta MD and Deborah W Sundlof DO (Presentation)
Management of Cardio-Oncology Emergencies, Ranju Gupta MD, Deborah W Sundlof DO, and Robert A. Watson (Presentation)
Management of Acute Myeloid Leukemia: A Review., Chetan Jeurkar, Lana King, David Baek, Lindsay Wilde, Gina Keiffer, and Margaret Kasner (Article)
Tagraxofusp after Transplant: A Phase I Safety Study of Post-HCT Maintenance in CD123+ Myeloid Malignancies, M Kasner (Article)
1O ATOMIC (A021502/AIO-KRK-0317): Does duration of adjuvant chemotherapy (chemo) or immunotherapy matter?, Maged Khalil MD (Article)
Modern Immunotherapy Landscape: IO, BiTEs, CAR-T and Practical Toxicity Pearls: Solid Tumor, Maged Khalil MD (Presentation)
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer., Dung T Le, Gunnar Folprecht, Anna M Varghese, Martin Gutierrez, Marcus Noel, Nikolaos A Trikalinos, Eric Chen, Farshid Dayyani, S Lindsey Davis, Wen Wee Ma, Atrayee BasuMallick, Ignacio Garrido-Laguna, Mayu Osawa, Shaun O'Brien, Ruslan D Novosiadly, Ke Xu, Danielle M Greenawalt, Santanu Dutta, Christina Twyman Saint Victor, and Heinz-Josef Lenz (Article)
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives., Sera Levy, Salimah Meghani, Brooke Worster, Colleen Kilanowski, Danielle Smith, Amy A Case, and Rebecca L Ashare (Article)
A-625 - SUPRAME: A Phase 3 trial evaluating anzutresgene autoleucel (anzu-cel, IMA203) PRAME-directed T-cell receptor T-cell therapy vs investigator’s choice in previously treated advanced cutaneous melanoma, Suresh G. Nair MD (Article)
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab in previously untreated, unresectable melanoma, Suresh G. Nair MD (Article)
Melanoma Update: TIL/IL-2 and Beyond, Suresh G. Nair MD (Presentation)
Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer., Shannon M Nugent, Rebecca L Ashare, Jennifer Cullen, Reina Haque, Jennifer Hu, Richard T Lee, Salimah H Meghani, Arnold L Potosky, Beth A Reboussin, Alfonso Romero-Sandoval, Kimberly G Wagoner, Yan Wang, Brooke Worster, Kelly K Filipski, and Andrew N Freedman (Article)
Analysis of Care and Outcomes for Stage IV Melanoma Patients at Lehigh Valley Topper Cancer Institute (2017-2023), Jake M. Panzer; Suresh G. Nair MD; and Melissa Kratz RN, MSN, AOCN (Poster)
A case report of gastroesophageal adenocarcinoma with yolk sac tumor differentiation in a pregnant patient., Rachel Patel DO, Alisha Hossain DO, Hiral N. Shah MD, Maged Khalil MD, and Roberto S Fratamico MD (Article)
Therapeutically Targetable Mutational Landscape of Anaplastic Thyroid Cancer., Murtaza Qazi, Muhammad Danyal Ahsan, Talar Telvizian MD, Samuel Laiacona, Nadir Ahmad, and Terri McHugh (Article)
Cardiac Autotransplantation for Cardiac Tumors: A Systematic Review., Daler Rahimov, Mila B Cooper, Matthew C Callesano, Nayeem Nasher, Aryana J Jones, Atrayee Basu Mallick, Eugene Storozynsky, Charles W Hoopes, and Vakhtang Tchantchaleishvili (Article)
Patient- and Caregiver-Identified Goals for Advance Care Planning in Patients With Dementia or Cognitive Impairment., Kristin L Rising, Angela M Gerolamo, Nazanin Sarpoulaki, Venise J Salcedo, Grace Amadio, Robin Casten, Anna Marie Chang, Alexzandra T Gentsch, C Virginia O'Hayer, Barry Rovner, and Brooke Worster (Article)
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer., Caio Max Sao Pedro Rocha Lima, Greg Yothers, Thomas J George, Howard S Hochster, Hanna K Sanoff, Deirdre J Cohen, Katherine A Guthrie, Samuel A Jacobs, Anwaar Saeed, Scott Kopetz, Linda H Colangelo, Tanner J Freeman, Scott W Cole, Maged Khalil MD, Swapna Devanna, Dan S Zuckerman, Theodore S Hong, N Lynn Henry, Patricia A Ganz, Charles D Blanke, Norman Wolmark, and Michael J Overman (Article)
Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects., Jennie E Ryan, Allison Herens, Mitchell Fruchtman, Philip Veliz, Erin L Kelly, and Brooke Worster (Article)
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer., Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, Walter R Peters, Robert J Behrens, Christopher H Lieu, Khalid Matin, Deirdre J Cohen, Samara L Potter, Andrew B Nixon, Lisa A Kottschade, Emily Kathol, Wendy L Frankel, Ardaman Shergill, Dennis Hsu, Anke Reinacher-Schick, Paul Mehan, Philip J Gold, Maged Khalil MD, Tyler Zemla, Clare Gatten, Eileen M O'Reilly, and Jeffrey A Meyerhardt (Article)
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination., James W Smithy, Victoria Ciallella, Claire Thant, Hannah L Kalvin, Jaykumar Thumar, Suresh G. Nair MD, Alexander Noor Shoushtari, Parisa Momtaz, Monica F Chen, Katherine S Panageas, Benjamin D Greenbaum, Neeman Mohibullah, and Michael A Postow (Article)
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination., James W Smithy, Victoria Ciallella, Claire Thant, Hannah L Kalvin, Jaykumar Thumar, Suresh G. Nair MD, Alexander Noor Shoushtari, Parisa Momtaz, Monica F Chen, Katherine S Panageas, Benjamin D Greenbaum, Neeman Mohibullah, and Michael A Postow (Article)
Treatment Patterns and Survival of Triple Negative Breast Cancer Patients Seen at Lehigh Valley Health Network, part of Jefferson Health (LVHN) from 2017-2022, Swarna Rishika Suresh; Savitri Skandan MD; and Melissa Kratz RN, MSN, AOCN (Poster)
Prospective Evaluation of “PreciseBreast” AI Tool in Early-Stage Invasive Breast Cancer Risk Stratification, Talar Telvizian MD (Article)
Therapeutically Targetable Mutational Landscape of Anaplastic Thyroid Cancer, Talar Telvizian MD (Article)
From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes., Joseph Van Galen, Jared A Daar, Usama Gergis, and Henry Fung (Article)
Short- and Long-term Metabolic Exposure Data as Predicators of Coronary Microvascular Dysfunction in a Positron Emission Tomography Myocardial Perfusion Imaging (PET-MPI) Cohort with Near Concurrent Angiography., Joseph Van Galen, Sarah J Ratcliffe, and Jamieson Bourque (Article)
Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development., Joseph Van Galen, Stephen D Willis, Ashish Bains, and Sara H Small (Article)
Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data., Steven G Waguespack, Marcia S Brose, Jessica J Lin, Ray McDermott, Mohammed Almubarak, Jessica Bauman, Michela Casanova, Shivaani Kummar, Se-Hoon Lee, Damian T Rieke, Do-Youn Oh, Changsong Qi, Natascha Neu, Domnita-Ileana Burcoveanu, Chiara E Mussi, Alexander Drilon, David S Hong, and Maria E Cabanillas (Article)
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004., William G Wierda; Kathleen A Dorritie; Jordan Gauthier; Rajneesh Nath; Thomas J Kipps; Peter A Riedell; Herbert A Eradat; Saad S Kenderian; Mohamed A Kharfan-Dabaja; Nirav N Shah; Scott R Solomon; Deborah M Stephens; Daniel A Ermann; Jon E Arnason; Abhinav Deol; Tatyana A Feldman; Charalambos Babis Andreadis; Monalisa Ghosh; Shuo Ma; Stephen J Schuster; Usama Gergis MD, MBA; Julie M Vose; Jacob D Soumerai; Koen van Besien; Sherilyn A Tuazon; Serena K Perna; San-San Ou; Revathi Ananthakrishnan; Neha Rane; Eniko Papp; Sahar Ansari; Ethan G Thompson; Abood Okal; Leanne Peiser; Yizhe Chen; Sanhita Sengupta; Pradipta Ranjan Ray; Jixian Wang; and Tanya Siddiqi (Article)
Cladribine (CLAD) + low-dose AraC (LDAC) + venetoclax (VEN) in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome: Real-world analysis from a large community-based oncology practice., Zachary Wolfe (Article)
An SMS-enhanced supportive program to improve treatment management and communication during active cancer treatment, B Worster (Article)
Association of iterative cannabis care plans with rates of symptom relief and side effect burden in oncology patients, B Worster (Article)
Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer., B Worster (Article)
Barriers to fertility preservation counseling in young cancer patients: A retrospective chart review, B Worster (Article)
Longitudinal ecological momentary assessment compliance among patients with cancer pain., B Worster (Article)
Oncology social work outreach as a predictor of oncology appointment completion among cancer patients with transportation needs., B Worster (Article)
Effectiveness and Impact of Telehealth-Integrated Palliative Care for Persons Living with Dementia and Their Caregivers., Brooke Worster, Lizabeth Kaminoff, Amina Mason, Laura Pontiggia, Kayla Madden, Mackenzie Kemp, Amanda Guth, Nina Diamond, Allison Herens, Kristin Rising, and Jeannette Kates (Article)
2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study., Yasuyuki Arai; Ruta Brazauskas; Naya He; A Samer Al-Homsi; Saurabh Chhabra; Minoo Battiwalla; Masamitsu Yanada; Amir Steinberg; Miguel Angel Diaz Perez; Sanghee Hong; Junya Kanda; Asad Bashey; Haydar A Frangoul; Sherif M Badawy; Leo F Verdonck; Hillard M Lazarus; Jean A Yared; Hasan Hashem; Akshay Sharma; Mahmoud Aljurf; Ajoy L Dias; Muhammad Bilal Abid; Baldeep Wirk; César O Freytes; Amer M Zeidan; Usama Gergis MD, MBA; Amer Beitinjaneh; Medhat Askar; Jeffrey J Pu; Leslie E Lehmann; Hemalatha G Rangarajan; William A Wood; Shahrukh Hashmi; Shingo Yano; Shinichi Kako; Yukiyasu Ozawa; Noriko Doki; Yoshinobu Kanda; Takahiro Fukuda; Yuta Katayama; Tatsuo Ichinohe; Junji Tanaka; Takanori Teshima; Shinichiro Okamoto; Yoshiko Atsuta; and Wael Saber (Article)
A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes., Karen A Autio, Christos E Kyriakopoulos, Paul Palyca MD, Han Xiao, Hamid Emamekhoo, Daniel Danila, Mehrin Jan, Victoria Catharine, Elyn Riedel, Michael Devitt, A Douglas Laird, and Howard I Scher (Article)
Change in T2-weighted signal intensity, change in tumor volume, and exposure-response analysis in the RINGSIDE phase 2 study of varegacestat in patients with desmoid tumors, A Basu Mallick (Article)
Subgroup analysis of the phase 2 part of the RINGSIDE phase 2/3 trial of varegacestat for treatment of desmoid tumors, A Basu Mallick (Article)
A Training Toolkit for Introducing Stem Cell Transplantation to the Inpatient Oncology Nurse, Susan G. Berg BSN, RN, CMSRN, OCN; Jenna Ruggiero BSN, RN; Jordan Mellinger Kish MSN, RN; Lisa Russo MSN, RN; Gavin Bauer BSN, RN; and Tammy Selby RN (Poster)
Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data, Xia Bi MD, MS (Article)
Assessing interest and satisfaction with integrative oncology approaches among hospitalized patients, Xia Bi MD, MS and Usama Gergis MD, MBA (Article)
Beyond Distraction: Music Therapy for Chronic Pain Management in People with Advanced Cancer., Joke Bradt, Lynn Gumert, Carrie Cottone, Ming Yuan Low, Clarissa Lacson, Kate Myers-Coffman, Karolina Bryl, Preethi Selvan, Jacelyn Biondo, Allison Millstein, Anna Cephas, Stephenie Sofield, Brooke Worster, and Amy E Leader (Article)
Efficacy and safety of larotrectinib in patients with TRK fusion thyroid carcinoma: An updated analysis, M Brose (Article)
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer., Marcia S Brose, C Benedikt Westphalen, Xiaoyun Pan, Vadim Bernard-Gauthier, Milena Kurtinecz, Helen Guo, Virginie Aris, Neil R Brett, Abdelali Majdi, Vivek Subbiah, Nathan A Pennell, Kenneth L Kehl, and Alexander Drilon (Article)
Efficacy and safety of larotrectinib as first-line treatment for adult patients with TRK fusion cancer, M S. Brose (Article)
Efficacy and safety of larotrectinib in patients with TRK fusion cancer who had a long-term response, M S. Brose (Article)
A descriptive study of the connections between social risk and healthcare utilization with supportive oncology care., Rebecca Cammy, Joshua Banks, Celeste Vaughan-Briggs, Gregory Garber, Steven Pantilat, and Brooke Worster (Article)
Synchronous Low-Grade Central Osteosarcoma and Ewing Sarcoma: A Rare Case Report., Daniel Christensen, Jeffrey A Belair, Atrayee BasuMallick, Scot A Brown, Michael Klein, and Wei Jiang (Article)
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in, Rossella Elisei, Lori J Wirth, Jaume Capdevila, Ana Oliveira Hoff, Makoto Tahara, Eric J Sherman, Mimi I Hu, Ming-Hua Ge, Jonathan Wadsley, Fernanda Vaisman, Katerina Kopeckova, Jolanta Krajewska, Dinorath Olvera, Collin Churchill, Patricia Maeda, Adrienne M Gilligan, Yan Lin, Nalin Payakachat, Bruce Robinson, Julien Hadoux, and Marcia S Brose (Article)
Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial), Usama Gergis MD, MBA (Article)
Outcomes of myeloablative vs reduced and non-myeloablative conditioning in MRD-negative AML and ALL with ptcy-based GVHD prophylaxis, Usama Gergis MD, MBA (Article)
Ask the experts: Community Engagement studios to inform research on cannabis use in cancer symptom management., Brittney Greene, Grace Mckenzie, Keenan Gibbons, Salimah H Meghani, Brooke Worster, and Rebecca L Ashare (Article)
Concordance of Management of Early and Locally Advanced Esophageal and Esophagogastric Junction Tumors with National Comprehensive Cancer Network Guidelines, Kanchan Gupta; Melissa Kratz RN, MSN, AOCN; Sean Quinlan-Davidson MD; and Savitri Skandan MD (Poster)
Impact of Adopting a Multidisciplinary Care Delivery Model on Treatment Effectiveness and Outcomes in Stage III Melanoma Patients at a Community-Based Academic Institution: A Retrospective Study., Zeeshan Hafeez MD; Aidan Johnson; Nicole Nester DO; Hariharasudan Mani MD; Aaron U. Blackham; Alyson McIntosh MD; Lauren Davis PA-C, MSPAS; Angela Miller RN; Alexandra Bauman; Morgan M. Horton BSN, RN, CCRC; and Suresh G. Nair MD (Article)
Prelude to the perfect storm: the many triggers of secondary hemophagocytic lymphohistiocytosis., Jordan B. Hatch DO, Elizabeth M Rich, Michael W Rich, Minh N Tran, and Daniel Wood (Article)
A retrospective analysis of the association of obesity with anthracycline- and trastuzumab-induced cardiotoxicity in the treatment of breast cancer and lymphoma., Mallorie L. Huff; Ranju Gupta MD; Rahul Gupta MD; Kelly C. Schadler MSN, CRNP; Shae Duka MPH; Vienna Histon-Figliolini; Joshua A. Kalter; Amogh M. Joshi DO; Nadeem V. Ahmad MD; Wilbert S Aronow; and Deborah W Sundlof DO (Article)
TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis., Ranakul Islam, Megan E Roche, Zhao Lin, Diana Whitaker-Menezes, Victor Diaz-Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J Philp, Atrayee Basu Mallick, and Ubaldo Martinez-Outschoorn (Article)
Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort., Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, A Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Soleen Ghafoor, Nicole E Benfante, Daniel V Rodriguez, Abraham R Meyerson, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G. Nair MD, Angelo A. Baccala MD, Paul Palyca MD, Bradley Lash, Muhammad A. Rizvi MD, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Jonathan E Rosenberg, Dean F Bajorin, and Jonathan A Coleman (Article)
A Century of Hypomethylating Agent: A Remarkable Response to Azacitidine Monotherapy for Relapsed Acute Myeloid Leukemia - A Case Report., Chetan Jeurkar, Amry Majeed, Lindsay Wilde, Gina Keiffer, and Margaret Kasner (Article)
How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain., Katie Fitzgerald Jones, Kevin T Liou, Rebecca L Ashare, Brooke Worster, Katherine A Yeager, Jessica Merlin, and Salimah H Meghani (Article)
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma., Thomas J Kaley, Christian Grommes, Elizabeth Coffee, Robert J Young, Tara Morrison MD, Ahmad Daher, Lauren R Schaff, Yufei Deng, Subhiksha Nandakumar, Eli L Diamond, Lisa M DeAngelis, Katherine S Panageas, Igor Gavrilovic, Andrew Lin, Elena Pentsova, Jacqueline Stone, Bianca D Santomasso, Anna F Piotrowski, Suresh G. Nair MD, Nikolaus Schultz, Anne S Reiner, and Ingo K Mellinghoff (Article)
Axon Regeneration and Functional Recovery after Spinal Cord Injury is Enhanced by Allele-Specific ApoE Neuronal Action through LRP8., Ramakrishnan Kannan, Xingxing Wang, LaShae Nicholson, Nancy Z Lin, Elisa M Howard, Atrayee Basu, Ines Ingabire, Yuichi Sekine, and Stephen M Strittmatter (Article)
Safety evaluation for less restrictive discharge criteria for patients receiving high dose methotrexate, M Kasner (Article)
Anexelekto (Axl)/Mer Inhibitor Tamnorzatinib in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: Results from a Phase I (Monotherapy) and Phase II (Combination with Venetoclax) Clinical Study., Margaret T Kasner, Nigel Courtenay-Luck, Courtney DiNardo, Sean M Post, Praneeth Baratam, George N Magrath, Takaaki Nakamura, Akifumi Fujii, Sergio Prados, Naoki Honda, Mary Mcbride, Paula Edwards-Holmes, and Robert Stuart (Article)
Acceptability and Preliminary Impact of Telehealth-Facilitated Integrated Palliative Care for Chronic Obstructive Pulmonary Disease., Jeannette Kates, Julia Katcher, Carrie Tompkins Stricker, Kristin L Rising, Mackenzie Kemp, Monika Pogorzelska-Maziarz, Julianna LeNoir, and Brooke Worster (Article)
Developing a patient-centered measure to assess food-related and nutrition-related quality of life in patients with cancer., Mackenzie Kemp, Sara Beachy, Karla Martin, Brooke Worster, Richard W Hass, Iyaniwura Olarewaju, Seth Berkowitz, and Kristin L Rising (Article)
Barriers to telehealth uptake and use: a scoping review., Mackenzie Kemp, Kristin L Rising, Gregory Laynor, Jessica Miao, Brooke Worster, Anna Marie Chang, Andrew J Monick, Amanda Guth, Tracy Esteves Camacho, Kiana McIntosh, Grace Amadio, Lindsey Shughart, TingAnn Hsiao, and Amy E Leader (Article)
Doc why am I so tired? Iron deficiency in the OB/GYN practice, Bradley Lash (Presentation)
Outpatient administration of epcoritamab monotherapy for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL): Results from EPCORE NHL-6 by race and ethnicity, Bradley Lash MD (Article)
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma., Daniel S Lefler, Andrew Elliott, Wei Jiang, Ubaldo Martinez-Outschoorn, Jude Al-Sabah, Daniel M Freed, Caitlin M King, Robert G Maki, Richard F Riedel, Jaime F Modiano, Daniel Hübschmann, Hanno Glimm, Stefan Fröhling, Matthew Oberley, Sosipatros A Boikos, and Atrayee Basu Mallick (Article)
Cannabis Stigma and Symptom Management Considerations in Cancer Survivors: A Mixed-Methods Exploration of Patient Perspectives., Sera Levy, Salimah Meghani, Brooke Worster, Colleen Kilanowski, Danielle Smith, Amy A Case, and Rebecca L Ashare (Article)
Sotorasib provides a durable response in high-grade metastatic ovarian serous adenocarcinoma harbouring KRAS G12C mutation., Hariharasudan Mani MD and Suresh G. Nair MD (Article)
Retrospective study of unresectable stage III or stage IV melanoma refractory to immune checkpoint and BRAF/MEK inhibitors, treated with triplet vs doublet therapy: A single institution experience, Hariharasudan Mani MD; Nicole Nester DO; Grace Rauscher; Timothy Johnson MD; Zeeshan Hafeez MD; Darshan Lal MD; Colby L. Presley; Hope Kincaid MPH, CPH; Alyson McIntosh MD; Aaron U. Blackham MD; and Suresh G. Nair MD (Article)
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer., Aaron P Mitchell, Andrew Salner, Paul Palyca MD, Azeez Farooki, Sonia Persaud, Nirjhar Chakraborty, Dedipya Bhamidipati, Maria Klimchuk, Michaela A Dinan, Michael S Leapman, Allison Lipitz-Snyderman, Anis Hamid, Jamie S Ostroff, and Michael J Morris (Article)
Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis., Kalyan V Nadiminti; Kwang W Ahn; Jinalben Patel; Qinghua Lian; Evandro Bezerra; Andy Chen; Siddhartha Ganguly; Usama Gergis MD, MBA; Hamza Hashmi; Mohamed A Kharfan-Dabaja; John Kuruvilla; Lazaros Lekakis; Frederick L Locke; Hemant Murthy; Muhamad Alhaj Mousthafa; Miguel-Angel Perales; Priyanka Pophali; Peter A Riedell; Nirav N Shah; Trent Wang; Marcelo Pasquini; Mehdi Hamadani; Cameron J Turtle; Alex F Herrera; and Mazyar Shadman (Article)
The role of urine derived exosome metalloproteinases as biomarkers for prostate cancer detection may be confounded by non-malignant prostatic inflammation., Jad Najdi, Layal Hajjar, Ola Hadadeh, Talar Telvizian MD, Christelle Dagher, Miza Salim Hammoud, Albert El Hajj, Wassim Abou-Kheir, Deborah Mukherji, and Marwan El-Sabban (Article)
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial., Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kaley, Jason M Melear, David M Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh G. Nair MD, Vinay K Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López-Janeiro, Carlos E de Andrea, Marta M Alonso, Paul Boutros, Joan Robbins, Warren P Mason, Adam M Sonabend, Roger Stupp, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, and Gelareh Zadeh (Article)
Variation in guideline-concordant use of bone modifying agents for prostate cancer, Paul Palyca MD (Article)
Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups., Omran Saifi, Chelsea C Pinnix, Chris R Kelsey, Leslie K Ballas, Sarah A Milgrom, Ranjana Advani, Margaret T Kasner, Stella Flampouri, Stephanie A Terezakis, Mark Sellmyer, John P Plastaras, and Bradford S Hoppe (Article)